GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Andrew S. Levey(Tufts Medical Center), Josef Coresh(New York University), Edmund J. Lewis, Lesley A. Inker(Tufts Medical Center), Alfred K. Cheung(University of Utah), Kerry Willis(National Kidney Foundation), Tom Greene(University Medical Center Groningen), Kunihiro Matsushita(Johns Hopkins University), Dick de Zeeuw(University Medical Center Groningen)
Cited by 597
Related Papers
A New Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2009|25.7k
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k